I am highly motivated and possess strong leadership qualities that will support the successful execution of the proposed research project. My professional background spans both clinical practice and medical research in academic and industry settings, providing rigorous training, extensive experience, and domain expertise. Throughout my career, I have remained committed to advancing diagnostic technologies. During my tenure in pediatric practice, I developed innovative clinical tests for asthma and allergic diseases (Lancet 8376:576, 1984; Annals of Allergy 54:317, 1985; Pediatrics 75:855, 1985). In my leadership role within the Hitachi Chemical–University of California Irvine collaborative program, I directed the development of multiple technologies and products for mRNA-based diagnostics (Nature 1357:519, 1992; Nature 367:759, 1994; J Immunol Methods 363:95, 2010), as well as extracellular vesicle (EV)-based mRNA diagnostics across nephrology (PLoS One 9:e109074, 2014), hematology (Clinical Chemistry 60:675, 2014), and gastroenterology (Inflammatory Bowel Diseases 22:1587, 2016). At this stage of my career, I am fully dedicated to the advancement of cell-type-specific EV-based diagnostics, since EVs represent a transformative frontier in the future of clinical diagnosis.